logo IMeN

Antioxidantes Nutricionais - Referências Bibliográficas

  1. Frei, B. Molecular and biological mechanisms of antioxidants action. FASEB, 1999;13: 963-964.
  2. Bjelakovic, G; Nikolova,D; Simonetti,RG; Gluud,C; Lancet; 2004; 364:1219-1228.
  3. Gey,KF. Prospects for tge prevention of free radical disease, regarding câncer and cardiovascular disease. Br Med Bull. 1993;49:679-99.
  4. Stampfer,MJ, Hennekens,CH, Manson, JE, et al. Vitamim E consumption and the risck of coronary disease in women. N Engl J Med. 1993;328:1444-9.
  5. Riemersma, RA, Wood, DA, MacIntyre, CCH, et al. Risk of angina pectoris and plasma concentrations of vitamina A, C, E and carotenoids. Lancet, 1991; 337:1-5.
  6. Ames , BN, Shinenaga, MK, Hagen , TM. Oxidants, antioxidants and the degenerative diseases of aging. Proc N Aca Sci. 1993; 90:7915-22.
  7. Coelho, OR; Cirillo, W. Antioxidantes na prevenção cardiovascular – o fim do mito? Rev Soc Cardiol Estado de São Paulo. 2002; 4:633-9.
  8. Correia, MITD. Antioxidação – o papel das vitaminas. Rev Bras Nutr Clin 2001; 16:59-67.
  9. Galizia, MS, Waitzberg, DL Mecanismo de ação dos radicais livres e antioxidantes Rev Bras Nutr Clin 2001; 16:79-89.
  10. Freedman, BA, Crapo, JD. Biology of disease: free radicals and tissue injury. Lab Invest 1982;47 (5): 412-26.
  11. Souza, HP, Laurindo, FRM Estresse oxidantivo e ruptura da placa aterosclerótica. Rev Soc Cardiol Estado de São Paulo. 2002; 4:584-94.
  12. Leninger , AL , Nelson DL, Cox, MM. Princípios de Bioquímica. 2ed. Sarvier: São Paulo, 1995.
  13. Poehlman,ET, Scheffers,J, Gottieb, SS, Fisher ML, Vaitekevicius P. Incresead resting metabolic rate in patients with heart failure. Ann Intern Med 1995; 121:860-2.
  14. Halliwell B Drug antioxidant effects. Drugs 1991;42:569-605.
  15. Halliwell B Cellular stress and protection mechanism. Biochem Soc Trans 1996; 24:1023-7.
  16. Murray RK. Red and white blood cells. In: Murray RK, Granner DK, mayes PA, Rodwell VW, eds. Harpe´s Biochemistry, 23 ed. Norwalk: Appleton and Lange; 1993 p688-703.
  17. Gutteridge JMC, Halliwell B. The measurement and mechanism of lipid peroxidation in biological systems. Trend Biochem Sci 1990; 15:129-35.
  18. Bobbio PA, Bobbio F. Química do Processamento dos Alimentos. 2ed. Varela: São Paulo; 1992.
  19. Fraticelli A, Serrano CV, Bochner BS, et al. Hydrogen peroxide and superoxide modulate leukocyte adhesion molecule expression and leucocyte endothelial adhesion. Biochim Biophys Acta 1996; 1310-251.
  20. Welbourn CRB, Young Y. Endotoxin, septic shock and acute lung injury: neurophils, macrophages and inflammatory mediators. British Journal of Surgery 1992; 79:998-1003.
  21. Parke AL, Ioannides C, Lewis DFV, Parke DV. Molecular pathology of drugs – disease interaction in chronic autoimmune inflammatory disease. Inflammopharmacology 1991; 1:3-36.
  22. Thomas, JA. Estresse oxidativo e defesa contra oxidants. In: Tratado de Nutrição Moderna na Saúde e na Doença. 9 ed. Manole: São Paulo. 2003; p801-812.
  23. Ross AC. Vitamina A e retinóides. In: Tratado de Nutrição Moderna na Saúde e na Doença. 9 ed. Manole: São Paulo. 2003; p325-350.
  24. WHO. Safe vitamin A dosage during pregnacy and lactation. Geneva : WHO;1998 34p (micronutrient series, WHO/NUT/98.4)
  25. Wald C. Carotenoids and visual cycle. J Genet Physiol 1935; 19:351-71.
  26. Dolinsky M, Ramalho A. Deficiência de vitamina A: uma revisão atualizada. Compacta Nutrição. 2003; 4(2):2-18.
  27. Institute of Medicine . Washington . National Academy Press, 2001.
  28. Darlow BA, Graham PJ. Vitamin A supplementation for preventing morbity and mortality in very low birthweight infants. Cochrane Database System Revist 2000;2:501-506.
  29. Stahl W, Sies H. Lycopene:a biologically important carotenoid for humans? Arch Biochem Biophys 1996;336(1): 1-9.
  30. Burton GW Antioxidant action of carotenoids. J Nutrition 1989; 119: 109-11.
  31. Heinonen OP, Huttenen JK, Albanes D, et al. N Engl J Med 1994; 330:1029-35.
  32. Ominen GS, Goodman GE, Thornquist MD, et al N Engl J Med 1996; 334:1150-5.
  33. Erhardt JG, Meisner C, Bode JC, Bode C Lycopene, ß-carotene, and colorectal adenomas Am. J. Clin Nutr 2003; 78: 1219 - 1224.
  34. Slattery ML, Benson J, Curtin K, Ma KN, Schaeffer D, Potter JD Carotenoids and colon cancer 1 Am J Clin Nutr 2000 71: 575-582.
  35. Michaud DS, Feskanich D, Rimm EB, Colditz GA, Speizer FE, Willett WC, Giovannucci E Intake of specific carotenoids and risk of lung cancer in 2 prospective US cohorts Am J Cli Nut 2000; 72(4):990-997.
  36. Terry P, Jain M, Miller AB, Howe GR, Rohan TE Dietary carotenoids and risk of breast cancer Am. J. Clin Nutr 2002; 76: 883 - 888
  37. Nkondjock A, Ghadirian P Intake of specific carotenoids and essential fatty acids and breast cancer risk in Montreal , Canada . Am. J. Clinical Nutrition 2004; 79: 857 - 864.
  38. Wu K, Erdman JW, Schwartz SJ, Platz EA, Leitzmann M,. Clinton SK , et al Plasma and Dietary Carotenoids, and the Risk of Prostate Cancer Cancer Epidemiol Biom Prev, 2004; 13: 260-269.
  39. Etminan M, Takkouche B, Isorna-Caamano F The role of tomate products and lycopene in the prevention of prostate cancer: a meta analysis of observational studies. Cancer Epodemiol Biomarkers Prev 2004; 13 (3): 340-45.
  40. Mayne ST FASEB J 1996; 10:690-701.
  41. Jacob RA Vitamina C. In: Tratado de Nutrição Moderna na Saúde e na Doença. 9 ed. Manole: São Paulo. 2003; p499-518.
  42. USDA Nutrient Database for Standard Reference, Release 14, 2001.
  43. Stadman ER. Prooxidant activity of ascorbic acid. Am J Clin Nutr 1991; 54:1125S-7S.
  44. Jailal I, Grundy SM, Preservation of the endogenous antioxidant in low density lipoprotein by ascorbate but not probucol during oxidative modification J Clin Invest 1991;87: 597-601.
  45. Thompson KH, Goldin DV. Micronutrients and antioxidants in the progression of diabetes. Nutrition Research 1995;15:1377-410.
  46. Hillstrom RJ, Yacapin-Ammons AK, Lynch SM. Vitamin C inhibits lipid oxidation in human HDL J Nutr 2003; 133:3047-51.
  47. Francis GA High density lipoprotein oxidation: in vitro susceptibility and potential in vivo consequences. Biochim Biophys Acta 2000; 1483:217-35.
  48. Jacob RA. Introduction: three eras of vitamin C discovery. In: Harris JR ed. Subcellular biochemistry, vol 25. Ascorbic Acid: biochemistry and biomedical cell biology. New York : Plenum Press, 1996: 1-16.
  49. Johnson RA, Baker SS, Fallon JT, Maynard EP, Ruskin JN, Wen Z, et al. An accidental case of cardiomyopathy and selenium deficiency. N Engl J Med 1981; 304:1210-2.
  50. Shenkin A. Micronutrients. In: Rombeau LJ & Rollandeli RH, eds. Enteral and tube feeding. Philadelphia : WB Sauders;1997.p96-111.
  51. Matsumoto S, Matsuo M, Niki E. Oxidation of vitamin E model compound 2,2,5,7,8-pentamethylchroman –6-ol, with the tert-butylperoxyl radical. J Chem Soc Chem Commun 1996:1076-77.
  52. Traber MG. Vitamina E Tratado de Nutrição Moderna na Saúde e na Doença. 9 ed. Manole: São Paulo. 2003; p369-386.
  53. Human Health and Disease, T.K. Basu, J.W. Dickerson, CAB International, 1996.
  54. Kathleen L, Escott-Stump S. Alimentos Nutrição e Dietoterapia. Ed Roca, 1998
  55. GISSI-Prevenzione Investigators (Gruppo Italiano per lo Studio della Sopravivenza nellÍnfarto Miocardico). Dietary supplementation with n-3 polynunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999; 354:447-55.
  56. The Heart Outcomes Prevention Evaluation Study Inverstigators. Vitamin E supplementation and cardiovascular events in high-risk patients. N Engl J Med 2000; 342:154-60.
  57. The Heart Protection Collaborative Group. MRC/BHF Heart Protection Study of antioxidants vitamin supplementation in 20536 high risk individuals: a randomized placebo-controlled trial. Lancet 2002; 360:23-33.
  58. Engelhart MJ, Geerlings MI, Ruitenberg A, van Swieten JC, Hofman A, Witteman JCM, et al Dietary Intake of Antioxidants and Risk of Alzheimer Disease JAMA  2002;287:3223-3229.
  59. Lembro A, Sardella A Química. 12 ed. Ática: São Paulo, 1992.
  60. Rice-Evans C, Miller NJ, Paganga G. Struture-antioxidant activity relationships of flavonoids and phenolic acids. Free Radc Biol Med 1996;20:933-956.
  61. Hammerstone JF, Lazarus SA, Schmitz HH. Procyanidin content and variation in some commonly consumed foods. J Nutr 2000; 130: 2086S-92S.
  62. Lazarus, SA, Hammerstone JF, Schmitz HH. Chocolate contains additional flavonoids not found in tea. Lancet 1999; 354:1825.
  63. Arts ICW, van de Putte B, Hollman PCH. Catechin contents of foods commonly consumed in The Netherlands J Agric Food Chem. Tea, wine, fruit juices, and chocolate milk. 2000;48:1752-57.
  64. Hertog MGL, Feskens EJM, Hollman PCH, Katan MB, Kromhout D. Dietary antioxidants flavonoids and risk for coronary heart disease: the Zutphen Elderly Study. Lancet 1993; 342:1007-11.
  65. Yang CS, Chung JY, Yang G, et al. Tea and tea polyphenols in cancer prevention J Nutr 2000;130:4725-85.
  66. De Logeril M et al. Circulation.1999; 99: 779-85
  67. Visioli F, Galli C Componentes antiaterogênicos do azeite de oliva. Current Atheros Rep Brasil. 2001; 1:107-13.
  68. Visioli F, Borsani L, Galli C. Diet and prevention of coronary heart disease: the potential role of phytochemicals. Cardiovasc Res 2000: 47:55-60.
  69. Marsilio V, Campestre C, Lanza B. Phenolic compounds change during California-style ripe olive processind. Food Chem. 2001;74:55-60.
  70. Carluccio MA, Siculella L, Ancora MA, massaro M, Scoditti E, et al. Olive oil and red wine antioxidant polyphenols inhibit endothelial activation Arterioscler Thromb Vasc Biol. 2003; 23:622-29.
  71. Bertelli AA, Gozzini A, Stradi R, Stella S, Bertelli A. Stability of resveratrol over time and in the various stages of grape transformation. Drugs Exp Clin Res 1998;24:207-211.
  72. Andlauer W et al. Clin Nutr Metab Care, 1:539-47,1998
  73. Costa RP, Silva CC, Pimentel IC Hábito alimentar e dislipidemias- Fundamentos para orientação dietética. In: Manual de dislipidemias e cardiometabolismo. São Paulo: BBS editora, 2004.
  74. Da Luz PL et al. Experimental and Molecular Pathology1999; 65:150-159
  75. III Diretrizes Brasileiras sobre Dislipidemia e Diretriz de Prevenção da Aterosclerose do Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia. Arq Bras Cardiol 77 (Supl III), nov 2001.
  76. PEREIRA, MA; JACOBS, DR Jr; PINS, JJ; et al. Effect of whole grains on insulin sensitivity in overweight hyperinsulinemic adults. Am J Clin Nutr; 75:848:55, 2002.
  77. SLAVIN, J; JACOBS, D; MARQUART, L. Whole grain consuption and chronic disease: protective mechanisms. Nutr Cancer1997; 27:14-21.
  78. SLAVIN, JL; MARTINI, MC; JACOBS, DR Jr; MARQUART, L. Plausible mechanisms for the protectiveness of whole grains. Am J Clin Nutr 1999; 70(suppl):459S-63S,.
  79. Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D, et al. The SU.VI.MAX study: a randomized, placebo-controlled trial of the health effects of antioxidants vitamins and minerals. Arch Intern Med, 2004 (in press)
trans 
Get Adobe Flash player

IMeN - Instituto de Metabolismo e Nutrição
Rua Abílio Soares, 233 cj 53 • São Paulo • SP • Fone: (11) 3287-1800 • 3253-2966 • administracao@nutricaoclinica.com.br